Inventor · disambiguated record
Zhonghui Lu
Also filed as: LU ZHONGHUI
19 granted patents·2 pending applications·112 citations·filing 2001–2024
92Inventor score
Top patents by PatentIndex Score
21 records- 0188US8846673B2Azaindazoles as kinase inhibitors and use thereofDUAN JINGWU·Filed 2010·Granted Sep 30, 2014·20 cites·16 claims
- 0287US6740649B2Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)BRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 25, 2004·31 cites·49 claims
- 0385US7595317B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Sep 29, 2009·7 cites·14 claims
- 0482US9458171B2Pyrrolidinyl sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 4, 2016·4 cites·14 claims
- 0582US7888381B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity, and use thereofBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Feb 15, 2011·6 cites·6 claims
- 0682US6984648B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 10, 2006·15 cites·21 claims
- 0782US6743807B2Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-αBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Jun 1, 2004·15 cites·42 claims
- 0877US7294624B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 13, 2007·9 cites·14 claims
- 0970US8987268B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Mar 24, 2015·2 cites·14 claims
- 1068US10865191B2Heterocyclic compounds useful as modulators of TNF alphaBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 15, 2020·1 cites·4 claims
- 1163US9771320B2Carbocyclic sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 26, 2017·1 cites·15 claims
- 1263US2025084056A1Substituted oxoisoindolinyl piperidine-2,6-dione compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1361US6936620B2Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinasesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·1 cites·21 claims
- 1456US11078186B2ROR γ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 3, 2021·0 cites·4 claims
- 1546US9663469B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 30, 2017·0 cites·6 claims
- 1645US9725443B2RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 8, 2017·0 cites·2 claims
- 1742US10308652B2Tricyclic heterocyclic compounds useful as inhibitors of TNFBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 4, 2019·0 cites·3 claims
- 1841US2016326108A1Pyrrolidinyl sulfone derivatives and their use as ror gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 1938US8921368B2Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesWROBLESKI STEPHEN T·Filed 2012·Granted Dec 30, 2014·0 cites·9 claims
- 2034US9637455B2Heterocyclic sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 2, 2017·0 cites·3 claims
- 2132US9708253B2Cyclohexyl sulfone RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 18, 2017·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Zhonghui Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →